Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated

NCT00025337 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

880

Enrollment

NIH

Sponsor class

Conditions

Adenocarcinoma of the Colon
Adenocarcinoma of the Rectum
Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage III Colon Cancer
Stage III Rectal Cancer
Stage IV Colon Cancer
Stage IV Rectal Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: oxaliplatin
DRUG: leucovorin calcium
DRUG: fluorouracil

Sponsor

National Cancer Institute (NCI)